BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28043186)

  • 21. Propranolol is more effective than pulsed dye laser and cryosurgery for infantile hemangiomas.
    Kagami S; Kuwano Y; Shibata S; Uwajima Y; Yamada D; Miyamoto A; Miyagawa T; Araki M; Takahashi K; Isomura S; Aozasa N; Masui Y; Yamamoto M; Inuzuka R; Katori T; Sato S
    Eur J Pediatr; 2013 Nov; 172(11):1521-6. PubMed ID: 23812512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of propranolol for complicated infantile hemangiomas.
    Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
    Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasound in assessing the efficacy of propranolol therapy for infantile hemangiomas.
    Shi H; Song H; Wang J; Xia L; Yang J; Shang Y; Zhou H
    Ultrasound Med Biol; 2014 Nov; 40(11):2622-9. PubMed ID: 25220276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
    Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
    Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nadolol for the treatment of infantile hemangioma.
    Villalba-Moreno AM; Cotrina-Luque J; Del Vayo-Benito CA; Flores-Moreno S; Bautista-Paloma FJ
    Am J Health Syst Pharm; 2015 Jan; 72(1):44-6. PubMed ID: 25511837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
    Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
    Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.
    de Graaf M; Breur JMPJ; Raphaël MF; Vos M; Breugem CC; Pasmans SGMA
    J Am Acad Dermatol; 2011 Aug; 65(2):320-327. PubMed ID: 21601311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propranolol therapy for infantile hemangioma: our experience.
    Zhang L; Wu HW; Yuan W; Zheng JW
    Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propranolol for severe infantile hemangiomas: follow-up report.
    Sans V; de la Roque ED; Berge J; Grenier N; Boralevi F; Mazereeuw-Hautier J; Lipsker D; Dupuis E; Ezzedine K; Vergnes P; Taïeb A; Léauté-Labrèze C
    Pediatrics; 2009 Sep; 124(3):e423-31. PubMed ID: 19706583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma.
    Aly MM; Hamza AF; Abdel Kader HM; Saafan HA; Ghazy MS; Ragab IA
    Eur J Pediatr; 2015 Nov; 174(11):1503-9. PubMed ID: 25982338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral propranolol for parotid infantile hemangiomas.
    Li G; Xu DP; Sun HL; Cheng C; Liu ZM; Xi SL; Wang XK
    J Craniofac Surg; 2015 Mar; 26(2):438-40. PubMed ID: 25692890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety profile during initiation of propranolol for treatment of infantile haemangiomas in an ambulatory day-care hospitalization setting.
    Fogel I; Ollech A; Zvulunov A; Valdman-Greenshpon Y; Atar Snir V; Friedland R; Lapidoth M; Ben-Amitai D
    J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):2004-2009. PubMed ID: 29573481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma.
    Frommelt P; Juern A; Siegel D; Holland K; Seefeldt M; Yu J; Uhing M; Wade K; Drolet B
    Pediatr Dermatol; 2016 Jul; 33(4):405-14. PubMed ID: 27246751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thirty-two Japanese cases of infantile hemangiomas treated with oral propranolol.
    Kagami S; Kaneko M; Katori T
    J Dermatol; 2018 Jun; 45(6):719-722. PubMed ID: 29603774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse effects of propranolol treatment for infantile hemangiomas in China.
    Jian D; Chen X; Babajee K; Su J; Li J; Hu X; Xie H; Li J
    J Dermatolog Treat; 2014 Oct; 25(5):388-90. PubMed ID: 23216314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral propranolol therapy in parotid hemangiomas: A retrospective comparison with other infantile hemangiomas.
    Wang L; Li S; Gao Q; Lv R; Xu G; Li X; Bi J; Huo R
    Head Neck; 2021 May; 43(5):1553-1562. PubMed ID: 33539620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial experience with a multidisciplinary strategy for initiation of propranolol therapy for infantile hemangiomas.
    Cushing SL; Boucek RJ; Manning SC; Sidbury R; Perkins JA
    Otolaryngol Head Neck Surg; 2011 Jan; 144(1):78-84. PubMed ID: 21493392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
    Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
    Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Propranolol in the treatment of problematic infantile hemangiomas].
    Lu J; Qin G; Huang J; Li S; Zhao J; Xiang Y; Chen J; Zuo C; Yang S; Tna L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1102-5. PubMed ID: 22169728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized controlled trial of propranolol for infantile hemangiomas.
    Hogeling M; Adams S; Wargon O
    Pediatrics; 2011 Aug; 128(2):e259-66. PubMed ID: 21788220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.